Drug
Pancrelipase
Pancrelipase: highest development phase Post-Market, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pancrelipase NCT03859869 | Post-Market | Exocrine Pancreatic Insufficiency (EPI) |
Latest
No recent events.
Follow Pancrelipase on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.